image credit- freepik
GCCL, a leading South Korea-based provider of clinical trial sample analysis, and US-based OPIS, a global full-service contract research organization (CRO), have signed a Memorandum of Understanding (MoU) to expand their collaboration and strengthen their position in the global clinical trial market.
At the signing ceremony, representatives from both companies discussed establishing a collaborative framework across multiple areas, including joint global clinical trial services, conducting joint projects, development of new business opportunities, and additional initiatives.
Through this collaboration, GCCL aims to expand strategic partnerships with global CROs and research organizations, strengthen its capability to deliver fully integrated clinical trial solutions across Asia, Europe, and the Americas, and extend tailored services to a broader range of biopharmaceutical companies.
